Yajima H, Kosukegawa A, Hoque M M, Shimojima T, Ishizu K, Takayama M, Sasaki Y, Sakai H, Otsuka M, Inokuchi S, Handa H
Faculty of Bioscience and Biotechnology, Tokyo Institute of Technology, 4259, Nagatsuta-cho, Midori-ku, Yokohama, 226, Japan.
Biochem Biophys Res Commun. 1996 Dec 24;229(3):778-87. doi: 10.1006/bbrc.1996.1880.
A new adenovirus vector carrying human-preproinsulin (h-PPI) genomic DNA, which was placed under the control of the mouse metallothionein gene promoter, was constructed. In the recombinant virus-infected cells, h-PPI gene expression increased as a function of ZnSO4 concentration. Reversed-phase high-performance liquid chromatography analysis revealed that the recombinant adenovirus-infected cells secreted immature insulin containing proinsulin and incorrectly processed insulin. Tyrosyl phosphorylation of human insulin receptor substrate 1 occurred when HepG2 cells were treated with the cultured medium, indicating that the h-PPI gene product was functionally active in vitro. We also examined the biological activity of the product using diabetic severe combined immunodeficient mice and confirmed that the h-PPI gene product reduced the blood glucose concentration in vivo. This study suggests that the adenovirus vector can be used to express a foreign gene under the control of an external promoter in various human cells.
构建了一种携带人胰岛素原前体(h-PPI)基因组DNA的新型腺病毒载体,该DNA置于小鼠金属硫蛋白基因启动子的控制之下。在重组病毒感染的细胞中,h-PPI基因表达随硫酸锌浓度的变化而增加。反相高效液相色谱分析表明,重组腺病毒感染的细胞分泌含有胰岛素原和加工错误的胰岛素的未成熟胰岛素。当用培养基处理HepG2细胞时,人胰岛素受体底物1发生酪氨酸磷酸化,表明h-PPI基因产物在体外具有功能活性。我们还使用糖尿病重症联合免疫缺陷小鼠检测了该产物的生物活性,并证实h-PPI基因产物在体内降低了血糖浓度。这项研究表明,腺病毒载体可用于在外部启动子的控制下在各种人类细胞中表达外源基因。